Logo image of ALLT

ALLOT LTD (ALLT) Stock Fundamental Analysis

USA - NASDAQ:ALLT - IL0010996549 - Common Stock

9.98 USD
+0.55 (+5.83%)
Last: 10/23/2025, 8:00:01 PM
9.9971 USD
+0.02 (+0.17%)
After Hours: 10/23/2025, 8:00:01 PM
Fundamental Rating

4

Taking everything into account, ALLT scores 4 out of 10 in our fundamental rating. ALLT was compared to 285 industry peers in the Software industry. While ALLT seems to be doing ok healthwise, there are quite some concerns on its profitability. ALLT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALLT had positive earnings in the past year.
In the past year ALLT had a positive cash flow from operations.
In the past 5 years ALLT always reported negative net income.
In the past 5 years ALLT reported 4 times negative operating cash flow.
ALLT Yearly Net Income VS EBIT VS OCF VS FCFALLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

ALLT has a Return On Assets (-1.31%) which is comparable to the rest of the industry.
ALLT's Return On Equity of -2.03% is in line compared to the rest of the industry. ALLT outperforms 58.60% of its industry peers.
Industry RankSector Rank
ROA -1.31%
ROE -2.03%
ROIC N/A
ROA(3y)-21.56%
ROA(5y)-15.33%
ROE(3y)-56.45%
ROE(5y)-37.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALLT Yearly ROA, ROE, ROICALLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of ALLT (70.06%) is comparable to the rest of the industry.
ALLT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-0.06%
ALLT Yearly Profit, Operating, Gross MarginsALLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

ALLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALLT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALLT has more shares outstanding
ALLT has a better debt/assets ratio than last year.
ALLT Yearly Shares OutstandingALLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALLT Yearly Total Debt VS Total AssetsALLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

There is no outstanding debt for ALLT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC9.31%
ALLT Yearly LT Debt VS Equity VS FCFALLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.09 indicates that ALLT has no problem at all paying its short term obligations.
ALLT has a Current ratio of 2.09. This is in the better half of the industry: ALLT outperforms 63.16% of its industry peers.
ALLT has a Quick Ratio of 1.88. This is a normal value and indicates that ALLT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALLT (1.88) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 1.88
ALLT Yearly Current Assets VS Current LiabilitesALLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 117.11% over the past year.
The Revenue has been growing slightly by 4.73% in the past year.
The Revenue has been decreasing by -3.49% on average over the past years.
EPS 1Y (TTM)117.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)4.73%
Revenue growth 3Y-14.13%
Revenue growth 5Y-3.49%
Sales Q2Q%8.51%

3.2 Future

ALLT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 123.87% yearly.
The Revenue is expected to grow by 12.33% on average over the next years. This is quite good.
EPS Next Y376%
EPS Next 2Y185.66%
EPS Next 3Y123.87%
EPS Next 5YN/A
Revenue Next Year9.05%
Revenue Next 2Y12.36%
Revenue Next 3Y9.6%
Revenue Next 5Y12.33%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALLT Yearly Revenue VS EstimatesALLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALLT Yearly EPS VS EstimatesALLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 76.77, the valuation of ALLT can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as ALLT.
When comparing the Price/Earnings ratio of ALLT to the average of the S&P500 Index (27.67), we can say ALLT is valued expensively.
Based on the Price/Forward Earnings ratio of 40.77, the valuation of ALLT can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ALLT.
The average S&P500 Price/Forward Earnings ratio is at 23.33. ALLT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 76.77
Fwd PE 40.77
ALLT Price Earnings VS Forward Price EarningsALLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALLT is valued a bit cheaper than the industry average as 61.05% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALLT indicates a somewhat cheap valuation: ALLT is cheaper than 64.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 43.77
EV/EBITDA 66
ALLT Per share dataALLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

ALLT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALLT's earnings are expected to grow with 123.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y185.66%
EPS Next 3Y123.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLOT LTD

NASDAQ:ALLT (10/23/2025, 8:00:01 PM)

After market: 9.9971 +0.02 (+0.17%)

9.98

+0.55 (+5.83%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners75.22%
Inst Owner Change0.08%
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap464.37M
Revenue(TTM)95.34M
Net Income(TTM)-2025000
Analysts85
Price Target15.3 (53.31%)
Short Float %2.07%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.66%
Min Revenue beat(2)2.97%
Max Revenue beat(2)12.36%
Revenue beat(4)3
Avg Revenue beat(4)3.83%
Min Revenue beat(4)-0.09%
Max Revenue beat(4)12.36%
Revenue beat(8)5
Avg Revenue beat(8)3.53%
Revenue beat(12)5
Avg Revenue beat(12)0.53%
Revenue beat(16)6
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 76.77
Fwd PE 40.77
P/S 4.87
P/FCF 43.77
P/OCF 38.6
P/B 4.66
P/tB 6.84
EV/EBITDA 66
EPS(TTM)0.13
EY1.3%
EPS(NY)0.24
Fwd EY2.45%
FCF(TTM)0.23
FCFY2.28%
OCF(TTM)0.26
OCFY2.59%
SpS2.05
BVpS2.14
TBVpS1.46
PEG (NY)0.2
PEG (5Y)N/A
Graham Number2.5
Profitability
Industry RankSector Rank
ROA -1.31%
ROE -2.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.06%
FCFM 11.13%
ROA(3y)-21.56%
ROA(5y)-15.33%
ROE(3y)-56.45%
ROE(5y)-37.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 21.59%
Cap/Sales 1.49%
Interest Coverage N/A
Cash Conversion 216.52%
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 1.88
Altman-Z N/A
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)45.91%
Cap/Depr(5y)90.1%
Cap/Sales(3y)3.32%
Cap/Sales(5y)4.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y376%
EPS Next 2Y185.66%
EPS Next 3Y123.87%
EPS Next 5YN/A
Revenue 1Y (TTM)4.73%
Revenue growth 3Y-14.13%
Revenue growth 5Y-3.49%
Sales Q2Q%8.51%
Revenue Next Year9.05%
Revenue Next 2Y12.36%
Revenue Next 3Y9.6%
Revenue Next 5Y12.33%
EBIT growth 1Y97.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year890.91%
EBIT Next 3Y162.43%
EBIT Next 5YN/A
FCF growth 1Y125.11%
FCF growth 3YN/A
FCF growth 5Y-26.21%
OCF growth 1Y131.56%
OCF growth 3YN/A
OCF growth 5Y-21.4%